Valuation: Instituto Rosenbusch S.A.

Market Cap 6.79B 4.56M 3.96M 3.69M 3.39M 6.4M 435M 6.5M 43.5M 17.07M 217M 17.13M 16.75M 727M P/E 2024
-3.67x
P/E 2025 -2.23x
Enterprise Value 7.53B 5.06M 4.4M 4.09M 3.76M 7.09M 483M 7.2M 48.22M 18.93M 240M 18.99M 18.57M 806M EV / Sales 2024
0.73x
EV / Sales 2025 1.71x
Free-Float
19.84%
Yield 2024 *
-
Yield 2025 -
1 day+0.63%
1 week+3.57%
1 month-2.15%
3 months-3.33%
6 months-26.50%
Current year-33.68%
1 week 155
Extreme 155
165
1 month 150
Extreme 150
165
Current year 128.5
Extreme 128.5
260
1 year 116
Extreme 116
357
3 years 21
Extreme 21
450
5 years 9.1
Extreme 9.1
450
10 years 4.2
Extreme 4.2
450
Manager TitleAgeSince
Director of Finance/CFO - 30/07/2010
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - 30/07/2010
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%+3.57%-31.25%+608.89% 4.56M
+1.66%+2.57%-47.56%-57.53% 32.4B
-0.34%+5.86%+91.23%+124.81% 13.17B
+0.48%+5.65%-15.72%+0.96% 3.84B
-1.17%+1.66%-0.74%+22.50% 3.25B
+7.85%+12.96%+48.36%+23.56% 2.04B
-1.45%+0.74%+2.10%+20.14% 1.89B
-0.33%+6.74%+39.14%+144.48% 1.47B
+1.73%+9.59%-20.13%-8.98% 1.14B
+1.24%+4.31%-13.95%-45.82% 989M
Average +1.03%+4.51%+5.15%+83.30% 6.02B
Weighted average by Cap. +1.05%+3.81%-4.63%+1.71%

Financials

2024 2025
Net sales 8.27B 5.56M 4.83M 4.5M 4.13M 7.79M 530M 7.91M 52.99M 20.8M 264M 20.86M 20.41M 885M 6.4B 4.3M 3.74M 3.48M 3.19M 6.03M 410M 6.12M 41M 16.09M 204M 16.15M 15.79M 685M
Net income -1.42B -952K -827K -770K -707K -1.33M -90.83M -1.36M -9.08M -3.56M -45.22M -3.57M -3.5M -152M -4.6B -3.09M -2.68M -2.5M -2.29M -4.33M -295M -4.4M -29.44M -11.55M -147M -11.59M -11.34M -492M
Net Debt 863M 580K 504K 469K 431K 813K 55.32M 826K 5.53M 2.17M 27.54M 2.18M 2.13M 92.35M 738M 495K 431K 401K 368K 695K 47.28M 706K 4.72M 1.85M 23.54M 1.86M 1.82M 78.93M
Logo Instituto Rosenbusch S.A.
Instituto Rosenbusch SA de Biologia Experimental Agropecuaria is an Argentina-based company primarily engaged in the production and sale of such veterinary products as antiparasitic drugs, vitamins, hormone treatments and vaccines, among others. The Company's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. It is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.
Employees
-
Date Price Change Volume
31/07/26 ARS 159.50 +0.63% 42,815
30/07/26 ARS 158.50 -1.55% 30,015
29/07/26 ARS 161.00 -0.62% 17,362
28/07/26 ARS 162.00 +1.57% 408
27/07/26 ARS 159.50 +3.57% 4,531
  1. Stock Market
  2. Stocks
  3. ROSE Stock